Recording of Analyst Briefing

Recording of Analyst Briefing

Melbourne, Australia — 09/06/2009

Analyst Briefing with CSL Managing Director and Chief Executive Officer, Dr Brian McNamee. This was recorded on June 9th 2009 following the announcement that CSL and Talecris Biotherapeutics have agreed to terminate the merger agreement.
PDF icon CSL and Talecris Biotherapeutics Agree to Terminate Merger Agreement (0.1Mb)


Listen Now

This recording is approximately 30 minutes long and can be listened to, stopped and restarted using the controls below.



Media Contacts: 
Australia 
Dr Rachel David
  Director, Public Affairs
  CSL Limited
  Telephone: +613 9389 1821
  Email: rachel.david@csl.com.au

Tim Duncan
  Hinton & Associates
  Telephone: +613 9600-1979
  Email: tduncan@hintons.com.au


United States 
Stan Neve & Robin Gilliland
  Brunswick Group
  Telephone: +1 212 333 3810
  Email: sneve@brunswickgroup.com

 
Investor Contact:Talecris Contact:
Mark Dehring
  Head of Investor Relations
  CSL Limited
  Telephone: +613 9389 2818
  Email: mark.dehring@csl.com.au
 Wendy Wilson
  Telephone: +1 919.316.2430
  Email: wendy.wilson@talecris.com

© 2016 CSL Limited